Isabela is the Global Project Head for the clinical development of the GM2 Gangliosidoses and Gaucher Disease programs at Sanofi devoted to chasing the miracles of science to improve people’s lives. As a dynamic and passionate leader in rare diseases, Isabela is responsible in building cross-functional teams to optimize development, execution and maximize efficiencies for clinical trials to ultimately provide disease modifying care to patients with rare diseases.
Isabela received her medical degree from the Carol Davila University of Medicine and Pharmacy in Bucharest, Romania. After spending several years in occupational health, she joined Sanofi and has been providing transformative therapeutic options to individuals with various cancers, cardiovascular diseases, and rare diseases for over two decades. She has co-authored several publications and has been an invited participant on several Think Tank meetings with the Food and Drug Association, National Institute of Health, and several academic institutions.